Tisza Party MEP In Cahoots With European Pharma Lobby

Andras Kulja, MEP for the Tisza Party, has met several times with pharmaceutical industry representatives and lobbyists. These meetings focus on reforms with enormous economic stakes.

Tisza Party President Peter Magyar and MEP Andras Kulja (Source: YouTube)

Kulja has also met with representatives from Johnson & Johnson to discuss general directives in EU health policy. According to its annual lobbying report, the American pharma giant spends over €500,000 (approx. 190 million HUF) and works with seven different lobbying firms in Brussels.

Based on this, it’s clear that Andras Kulja frequently engages with pharma lobbyists and industry representatives. While such meetings are not illegal,"Whose interests are truly being represented by politicians who so regularly consult with billion-euro corporations?”

The Tuzfalcsoport portal raises the legitimate question.

Under current EU transparency rules, it’s often unclear in real-time which specific legislative drafts and policy directions are being influenced behind the scenes by such corporate interests.

Cover image: Tisza Party President Peter Magyar and MEP Andras Kulja (Source: YouTube)